Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Urogynecology Journal
Published in: International Urogynecology Journal 8/2011

01-08-2011 | Original Article

Goal attainment scaling in patients with lower urinary tract symptoms: development and pilot testing of the Self-Assessment Goal Achievement (SAGA) questionnaire

Authors: Linda Brubaker, Vik Khullar, Elisabeth Piault, Christopher J. Evans, Tamara Bavendam, James Beach, Yating Yeh, Zoe S. Kopp, Con J. Kelleher, Jeffrey Trocio

Published in: International Urogynecology Journal | Issue 8/2011

Login to get access

Abstract

Introduction and hypothesis

The Self-Assessment Goal Achievement (SAGA) questionnaire was developed to identify treatment goals and assess goal-achievement in patients with lower urinary tract symptoms (LUTS).

Methods

This study consisted of (1) gathering information on goal setting/attainment concepts, (2) goal elicitation (n = 41 patients with LUTS), (3) cognitive debriefing of draft questionnaire (n = 11), and (4) pilot testing (n = 104).

Results

SAGA consists of baseline (goal-assessment; ranking) and follow-up (goal-achievement) modules. In addition to goals most frequently mentioned, patients can list up to five open goals. Goals most commonly reported as “very important” in pilot testing included reducing urgency (72%), incontinence (65%), and nocturia (64%). Treatment goals spontaneously reported as “very important” were reducing incontinence (45%), nocturia (40%), and frequency (26%).

Conclusions

SAGA may be used to identify treatment goals and assess goal-achievement in patients with LUTS in the clinic and for research (with additional validation). This information may promote patient–physician interaction and help patients establish realistic treatment goals, which may in turn improve treatment adherence and outcomes.
Literature
1.
Brubaker L, Chapple C, Coyne KS, Kopp Z (2006) Patient-reported outcomes in overactive bladder: importance for determining clinical effectiveness of treatment. Urology 68:3–8PubMedCrossRef
2.
Elkadry EA, Kenton KS, FitzGerald MP, Shott S, Brubaker L (2003) Patient-selected goals: a new perspective on surgical outcome. Am J Obstet Gynecol 189:1551–1557PubMedCrossRef
3.
Benner JS, Nichol MB, Rovner ES, Jumadilova Z, Alvir J, Hussein M et al (2010) Patient-reported reasons for discontinuing overactive bladder medication. BJU Int 105:1276–1282PubMedCrossRef
4.
Marschall-Kehrel D, Roberts RG, Brubaker L (2006) Patient-reported outcomes in overactive bladder: the influence of perception of condition and expectation for treatment benefit. Urology 68(suppl 2A):29–37PubMedCrossRef
5.
Irwin DE, Abrams P, Milsom I, Kopp Z, Reilly K (2008) Understanding the elements of overactive bladder: questions raised by the EPIC study. BJU Int 101:1381–1387PubMedCrossRef
6.
Elinoff V, Bavendam T, Glasser DB, Carlsson M, Eyland N, Roberts R (2006) Symptom-specific efficacy of tolterodine extended release in patients with overactive bladder: the IMPACT trial. Int J Clin Pract 60:745–751PubMedCrossRef
7.
8.
Khan MS, Chaliha C, Leskova L, Khullar V (2005) A randomized crossover trial to examine administration techniques related to the Bristol female lower urinary tract symptom (BFLUTS) questionnaire. Neurourol Urodyn 24:211–214PubMedCrossRef
9.
MacDiarmid S, Rosenberg M (2005) Overactive bladder in women: symptom impact and treatment expectations. Curr Med Res Opin 21:1413–1421PubMedCrossRef
10.
Nicolson P, Kopp Z, Chapple CR, Kelleher C (2008) It’s just the worry about not being able to control it! A qualitative study of living with overactive bladder. Br J Health Psychol 13:343–359PubMedCrossRef
11.
Sung VW, Raker CA, Myers DL, Clark MA (2010) Treatment decision-making and information-seeking preferences in women with pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct 21:1071–1078CrossRef
12.
Kiresuk TJ, Lund SH, Larsen NE (1982) Measurement of goal attainment in clinical and health care programs. Drug Intell Clin Pharm 16:145–153PubMed
13.
Ashford S, Turner-Stokes L (2006) Goal attainment for spasticity management using botulinum toxin. Physiother Res Int 11:24–34PubMedCrossRef
14.
Hullfish KL, Bovbjerg VE, Gibson J, Steers WD (2002) Patient-centered goals for pelvic floor dysfunction surgery: what is success, and is it achieved? Am J Obstet Gynecol 187:88–92PubMedCrossRef
15.
Brubaker L, Kopp Z, Piault E, Trocio J, Evans C, Fitzgerald K, et al (2007) Development of a Self-Assessment Goal Achievement (SAGA) questionnaire in urinary disorders. Paper presented at International Continence Society, Rotterdam, The Netherlands, August 20–24, 2007
16.
Fianu-Jonasson A, Brubaker L, Kelleher C, Khullar V, Bitoun CE, Weinstein D, et al (2009) Understanding Swedish patients’ expectations for treatment of their urinary symptoms. Paper presented at Nordic Urogynecological Association, Reykjavik, Iceland, May 14–16, 2009
17.
Mahajan ST, Elkadry EA, Kenton KS, Shott S, Brubaker L (2006) Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery. Am J Obstet Gynecol 194:722–728PubMedCrossRef
18.
Payne C, Allee T (2009) Goal achievement provides new insights into interstitial cystitis/painful bladder syndrome symptoms and outcomes. Neurourol Urodyn 28:13–17PubMedCrossRef
19.
Milne JL, Robert M, Tang S, Drummond N, Ross S (2009) Goal achievement as a patient-generated outcome measure for stress urinary incontinence. Health Expect 12:288–300PubMedCrossRef
20.
Lowenstein L, FitzGerald MP, Kenton K, Dooley Y, Templehof M, Mueller ER et al (2008) Patient-selected goals: the fourth dimension in assessment of pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct 19:81–84PubMed
21.
US Department of Health and Human Services (2009) Patient-reported outcome measures: use in medical product development to support labeling claims. Health Qual Life Outcomes 4:79
22.
Charmaz K (1995) Grounded theory. In: Smith JA, Harre R, Van Langenhove L (eds) Rethinking methods in psychology. Sage, London, pp 27–49
23.
Strauss A, Corbin J (1998) Basics of qualitative research: Techniques and procedures for developing grounded theory. Sage, London
24.
Charmaz K (1991) Good days, bad days: The self in chronic illness and time. Rutgers University Press, New Brunswick
25.
Glaser B, Strauss AL (1967) The constant comparative methods of qualitative analysis. In: Discovery of grounded theory. Aldine de Gruyter, New York, p 101
26.
Coyne K, Revicki D, Hunt T, Corey R, Stewart W, Bentkover J et al (2002) Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res 11:563–574PubMedCrossRef
27.
Piault E, Evans CJ, Espindle D, Kopp Z, Brubaker L, Abrams P (2008) Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire. Neurourol Urodyn 27:179–190PubMedCrossRef
28.
Krueger KP, Berger BA, Felkey B (2005) Medication adherence and persistence: a comprehensive review. Adv Ther 22:313–356PubMedCrossRef
29.
Shaya FT, Blume S, Gu A, Zyczynski T, Jumadilova Z (2005) Persistence with overactive bladder pharmacotherapy in a Medicaid population. Am J Manag Care 11:S121–S129PubMed
30.
Rockwood K, Stolee P, Fox RA (1993) Use of goal attainment scaling in measuring clinically important change in the frail elderly. J Clin Epidemiol 46:1113–1118PubMedCrossRef
Metadata
Title
Goal attainment scaling in patients with lower urinary tract symptoms: development and pilot testing of the Self-Assessment Goal Achievement (SAGA) questionnaire
Authors
Linda Brubaker
Vik Khullar
Elisabeth Piault
Christopher J. Evans
Tamara Bavendam
James Beach
Yating Yeh
Zoe S. Kopp
Con J. Kelleher
Jeffrey Trocio
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
International Urogynecology Journal / Issue 8/2011
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-011-1382-7

Other articles of this Issue 8/2011

International Urogynecology Journal 8/2011 Go to the issue

Original Article

The relationship between anthropometric measurements and the bony pelvis in African American and European American women

Clinical Opinion

Mixed urinary incontinence—time to uncouple urgency from stress?

Original Article

Tridimensional sonographic anatomical changes on pelvic floor muscle according to the type of delivery

Original Article

Urethral compensatory mechanisms to maintain urinary continence after pudendal nerve injury in female rats

Original Article

The role of preoperative oral vitamin B in the cystoscopic assessment of ureteric patency

Case Report

Primary menouria due to a congenital vesico–vaginal fistula with distal vaginal agenesis: a rarity